Home Cart Sign in  
Chemical Structure| 480-18-2 Chemical Structure| 480-18-2

Structure of Taxifolin
CAS No.: 480-18-2

Chemical Structure| 480-18-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Taxifolin ((+)-Dihydroquercetin) shows significant anti-tyrosinase activity and inhibits collagenase with an IC50 of 193.3 μM. It is a notable natural compound with antifibrotic activity and serves as a free radical scavenger with antioxidant properties.

Synonyms: (+)-Dihydroquercetin; Dihydroquercetin; Catechin hydrate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Tuba Unver ;

Abstract: Aim: Taxifolin (dihydroquercetin) is a natural bioactive flavonoid with antifungal, antiviral, antibacterial, antioxidant, and anti-inflammatory properties, and is a valuable compound in the medical, pharmaceutical, and food industries. This study aims to determine the Minimum Inhibitory Concentration (MIC) of pure taxifolin (99.25%) against pathogenic and opportunistic microorganisms. Materials and Methods: The antibacterial and antifungal activities of taxifolin against two Gram-positive (E. aerogenes, S. aureus), three Gram-negative (P. aeruginosa, K. pneumonia and E. coli), and four yeast strains (C. krusei, C. glabrata, C. tropicalis and C. albicans) was determined using agar and broth microdilution methods. Results: The MIC value for tested Gram-positive bacteria is 1 mg/mL, which is 2 mg/ml for Gram-negative bacteria. At the same time, the MIC value was 8 mg/mL for all Candida species tested except C. glabrata (MIC: 4 mg/mL). Conclusion: In conclusion, it was determined that the antibacterial property of taxifolin was more pronounced than its antifungal properties. Taxifolin is a natural compound with high medical and pharmacological value. This study proved the effectiveness of pure taxifolin as a pharmacotherapeutic agent on pathogenic and opportunistic microorganisms. The preliminary data collected in this study should be further supported, and in vivo and bioavailability studies should be detailed in future studies.

Keywords: Taxifolin ; Dihydroquercetin ; Antibacterial activity ; Antifungal activity ; Pharmaceutical agent ; Antimicrobials

Purchased from AmBeed:

Alternative Products

Product Details of Taxifolin

CAS No. :480-18-2
Formula : C15H12O7
M.W : 304.25
SMILES Code : O=C1[C@H](O)[C@@H](C2=CC=C(O)C(O)=C2)OC3=C1C(O)=CC(O)=C3
Synonyms :
(+)-Dihydroquercetin; Dihydroquercetin; Catechin hydrate
MDL No. :MFCD15146487
InChI Key :CXQWRCVTCMQVQX-LSDHHAIUSA-N
Pubchem ID :439533

Safety of Taxifolin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Taxifolin

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HepG2 cells 25 and 50 μM 24 hours Taxifolin and sorghum ethanol extract increased glucose uptake and enhanced the expression of p-PI3K, p-IRS1, p-AKT, p-AMPK, and p-ACC, indicating that they alleviated insulin resistance by regulating miR-195 expression. PMC8465682
BV-2 mouse microglial cells 50 μM 24 hours To investigate the inhibitory effects of Taxifolin on inflammatory responses in microglia under high-glucose conditions, the results showed that Taxifolin significantly reduced IL-1β production by decreasing intracellular ROS levels and inhibiting the activation of the TXNIP–NLRP3 axis. PMC10302635
AGS cells 1, 3, 10, 30, 100 µM 48 hours To examine the effects of Tax on the viability of AGS cells, results showed that Tax significantly inhibited the viability of AGS cells PMC8448545
NCI-N87 cells 1, 3, 10, 30, 100 µM 48 hours To examine the effects of Tax on the viability of NCI-N87 cells, results showed that Tax significantly inhibited the viability of NCI-N87 cells PMC8448545

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Tg-SwDI mouse model Oral 3% Taxifolin Continued for 7 to 13 months Taxifolin exhibited pleiotropic neuroprotective effects on CAA model mice by suppressing amyloid-β production and modulating proinflammatory microglial phenotypes. PMC6525485
Mice Tg-SwDI mice Oral 3% taxifolin From 1 month of age until death Taxifolin inhibited amyloid-β1-40 assembly and oligomer formation, restored cerebral blood flow and cerebrovascular reactivity, reduced amyloid-β accumulation, and improved spatial reference memory in Tg-SwDI mice. PMC5379578
Wistar rats Streptozotocin-induced diabetic model Oral 50 mg/kg/day Once daily for 28 days To evaluate the protective effects of TS in diabetic rats, the results showed that TS treatment reduced fasting blood glucose levels, improved glucose tolerance, and had protective effects on pancreatic and liver tissues. PMC10418707
BALB/c Nude mice gastric cancer xenograft model intraperitoneal injection 25 mg/kg twice weekly for 21 days To examine the effects of Tax on tumor growth in gastric cancer xenograft model, results showed that Tax significantly suppressed tumor growth PMC8448545
Mice DSS-induced ulcerative colitis model Oral 200 mg/kg Once daily for 7 consecutive days Taxifolin alleviates DSS-induced colitis by altering gut microbiota to increase the production of butyric acid. PMC8912346
Rats Spontaneously Hypertensive Rats (SHR) Oral 20 mg/kg/day Once daily for 10 days Taxifolin reduced blood pressure in spontaneously hypertensive rats, improved vascular function, and mitigated the vascular inflammatory response. PMC10454553

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.29mL

0.66mL

0.33mL

16.43mL

3.29mL

1.64mL

32.87mL

6.57mL

3.29mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories